Zevra Therapeutics, Inc. ZVRA License — Contract with customer, liability
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s license — contract with customer, liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s license — contract with customer, liability?
- Zevra Therapeutics, Inc. (ZVRA) reported license — contract with customer, liability of $0 in Q1 2026.
- What does license — contract with customer, liability mean?
- This metric reflects the balance of payments received from customers for which the company has not yet satisfied its performance obligations under a licensing agreement. It represents a future obligation to provide goods or services, often referred to as deferred revenue.